1. Safety and efficacy of repeat thrombolytic treatment after acute myocardial infarction;White, H.D.; Cross, D.B.; Williams, B.F.; Norris, R.M.,1990
2. Immunoglobulin response to intravenous streptokinase in acute myocardial infarction;Lynch, M.; Littler, W.A.; Pentecost, B.L.; Stockley, R.A.;Br HeartJ,1991
3. Streptokinase resistance: when might streptokinase be ineffective?;Buchalter, M.B.; Suntharalingam, G.; Jennings, I.; Hart, C.; Luddington, R.J.; Chakraverty, R.;Br HeartJ,1992
4. Monitoring of streptokinase resistance titre in acute myocardial infarction patients up to 30 months after giving streptokinase or anistreplase and related studies to measure specific antistreptokinase IgG;Fears, R.; Ferres, H.; Glasgow, E.; Standring, R.; Hogg, K.J.; Gemmill, J.D.,1992
5. Antistreptokinase titres after intravenous streptokinase;Jalihal, S.; Morris, G.K.;Lancet,1990